Re: Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis

被引：0
作者：
Cigliola, Antonio [1 ]
Mercinelli, Chiara [1 ]
Patane, Damiano [1 ]
Raggi, Daniele [1 ]
Necchi, Andrea [1 ,2 ]
机构：
[1] IRCCS Osped San Raffaele, Dept Med Oncol, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
来源：
EUROPEAN UROLOGY | 2023年 / 84卷 / 06期
关键词：
CISPLATIN; NIVOLUMAB;
D O I：
10.1016/j.eururo.2023.06.026
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：602 / 603
页数：2
相关论文
共 50 条
  • [41] The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study
    Wahafu, Wasilijiang
    Liu, Sai
    Xu, Wenbin
    Wang, Mengtong
    He, Qingbao
    Song, Liming
    Wang, Mingshuai
    Yang, Feiya
    Hua, Lin
    Niu, Yinong
    Xing, Nianzeng
    [J]. BMC UROLOGY, 2019, 19 (01)
  • [42] Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer
    Horiguchi, Hirotaka
    Hatakeyama, Shingo
    Yoneyama, Tohru
    Yoneyama, Mihoko Sutoh
    Tanaka, Toshikazu
    Fujita, Naoki
    Okamoto, Teppei
    Yamamoto, Hayato
    Yoneyama, Takahiro
    Yoshizawa, Tadashi
    Hashimoto, Yasuhiro
    Kawaguchi, Toshiaki
    Ohyama, Chikara
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (04) : 238.e9 - 238.e17
  • [43] Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial
    Szabados, Bernadett
    Rodriguez-Vida, Alejo
    Duran, Ignacio
    Crabb, Simon J.
    Van der Heijden, Michiel S.
    Pous, Albert Font
    Gravis, Gwenaelle
    Herranz, Urbano Anido
    Protheroe, Andrew
    Ravaud, Alain
    Maillet, Denis
    Mendez-Vidal, Maria J.
    Suarez, Cristina
    Linch, Mark
    Prendergast, Aaron
    Tyson, Charlotte
    Mousa, Kelly
    Castellano, Daniel
    Powles, Thomas
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (03): : 456 - 463
  • [44] Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
    Galsky, Matthew D.
    Pal, Sumanta K.
    Chowdhury, Simon
    Harshman, Lauren C.
    Crabb, Simon J.
    Wong, Yu-Ning
    Yu, Evan Y.
    Powles, Thomas
    Moshier, Erin L.
    Ladoire, Sylvain
    Hussain, Syed A.
    Agarwal, Neeraj
    Vaishampayan, Ulka N.
    Recine, Federica
    Berthold, Dominik
    Necchi, Andrea
    Theodore, Christine
    Milowsky, Matthew I.
    Bellmunt, Joaquim
    Rosenberg, Jonathan E.
    [J]. CANCER, 2015, 121 (15) : 2586 - 2593
  • [45] Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study
    Hu, Jiao
    Chen, Jinbo
    Ou, Zhenyu
    Chen, Haige
    Liu, Zheng
    Chen, Minfeng
    Zhang, Ruiyun
    Yu, Anze
    Cao, Rui
    Zhang, Enchong
    Guo, Xi
    Peng, Bo
    Deng, Dingshan
    Cheng, Chunliang
    Liu, Jinhui
    Li, Huihuang
    Zou, Yihua
    Deng, Ruoping
    Qin, Gang
    Li, Wenze
    Wang, Lue
    Chen, Tao
    Pei, Xiaming
    Gong, Guanghui
    Tang, Jiansheng
    Othmane, Belaydi
    Cai, Zhiyong
    Zhang, Chunyu
    Liu, Zhi
    Zu, Xiongbing
    [J]. CELL REPORTS MEDICINE, 2022, 3 (11)
  • [46] A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database
    Fischer-Valuck, Benjamin W.
    Michalski, Jeff M.
    Contreras, Jessika A.
    Brenneman, Randall
    Christodouleas, John P.
    Abraham, Christopher D.
    Kim, Eric H.
    Arora, Vivek K.
    Bullock, Arnold D.
    Carmona, Ruben
    Figenshau, Robert S.
    Grubb, Robert, III
    Knoche, Eric M.
    Pachynski, Russell K.
    Picus, Joel
    Roth, Bruce J.
    Sargos, Paul
    Andriole, Gerald L.
    Gay, Hiram A.
    Baumann, Brian C.
    [J]. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 15 : 38 - 41
  • [47] Perioperative chemotherapy and immunotherapy to optimize cystectomy outcomes in the curative intent of non-metastatic muscle-invasive bladder cancer: A systematic review and meta-analysis
    Boutaleb, Ismail
    Mjaess, Georges
    Roumeguere, Thierry
    [J]. FRENCH JOURNAL OF UROLOGY, 2024, 34 (09):
  • [48] No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study
    Jerlstrom, Tomas
    Chen, Ruoqing
    Liedberg, Fredrik
    Andren, Ove
    Strock, Viveka
    Aljabery, Firas A. S.
    Hosseini, Abolfazl
    Sherif, Amir
    Malmstrom, Per-Uno
    Ullen, Anders
    Gardmark, Truls
    Fall, Katja
    [J]. WORLD JOURNAL OF UROLOGY, 2020, 38 (02) : 381 - 388
  • [49] Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre experience
    Boeri, Luca
    Soligo, Matteo
    Frank, Igor
    Boorjian, Stephen A.
    Thompson, Robert H.
    Tollefson, Matthew
    Quevedo, Fernando J.
    Cheville, John C.
    Karnes, Robert Jeffrey
    [J]. BJU INTERNATIONAL, 2019, 123 (06) : 1011 - 1019
  • [50] Patterns of Recurrence and Long-Term Survival of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Locally Advanced Esophageal Cancer Treated with Neoadjuvant Chemotherapy: a Propensity Score-Matched Analysis
    Sugimura, Keijiro
    Miyata, Hiroshi
    Kanemura, Takashi
    Takeoka, Tomohira
    Sugase, Takahito
    Masuzawa, Toru
    Katsuyama, Shinnsuke
    Motoori, Masaaki
    Takeda, Yutaka
    Murata, Kohei
    Yano, Masakiho
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (06) : 1055 - 1065
12345